These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9812199)

  • 21. The degradation of platelet-activating factor by high-density lipoprotein in rat plasma. Effect of ethynyloestradiol administration.
    Pritchard PH
    Biochem J; 1987 Sep; 246(3):791-4. PubMed ID: 3689334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of the paraoxonase and platelet-activating factor acetylhydrolase activities with aging.
    Milochevitch C; Khalil A
    Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):241-6. PubMed ID: 11993715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins.
    Mackness MI; Mackness B; Durrington PN; Connelly PW; Hegele RA
    Curr Opin Lipidol; 1996 Apr; 7(2):69-76. PubMed ID: 8743898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.
    MacPhee CH; Moores KE; Boyd HF; Dhanak D; Ife RJ; Leach CA; Leake DS; Milliner KJ; Patterson RA; Suckling KE; Tew DG; Hickey DM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):479-87. PubMed ID: 10024526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of plasma free cholesterol from circulating lipoprotein-associated cholesteryl ester.
    Goldberg IJ; Rosenfeld RS; Paul I; Leeman B
    Am J Physiol; 1986 Mar; 250(3 Pt 1):E265-8. PubMed ID: 3953812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dialysis Modalities and HDL Composition and Function.
    Holzer M; Schilcher G; Curcic S; Trieb M; Ljubojevic S; Stojakovic T; Scharnagl H; Kopecky CM; Rosenkranz AR; Heinemann A; Marsche G
    J Am Soc Nephrol; 2015 Sep; 26(9):2267-76. PubMed ID: 25745027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy.
    Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP
    Scand J Clin Lab Invest; 2000 May; 60(3):189-98. PubMed ID: 10885490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis.
    De Geest B; Stengel D; Landeloos M; Lox M; Le Gat L; Collen D; Holvoet P; Ninio E
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E68-75. PubMed ID: 11031226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism.
    Dullaart RP; Sluiter WJ; Dikkeschei LD; Hoogenberg K; Van Tol A
    Eur J Clin Invest; 1994 Mar; 24(3):188-94. PubMed ID: 8033953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 20 days' bed rest on the reverse cholesterol transport system in healthy young subjects.
    Yanagibori R; Kondo K; Suzuki Y; Kawakubo K; Iwamoto T; Itakura H; Gunji A
    J Intern Med; 1998 Apr; 243(4):307-12. PubMed ID: 9627145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HDL: the metabolism, function, and therapeutic importance.
    Wang M; Briggs MR
    Chem Rev; 2004 Jan; 104(1):119-37. PubMed ID: 14719972
    [No Abstract]   [Full Text] [Related]  

  • 32. Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general population.
    Knoblauch H; Bauerfeind A; Krähenbühl C; Daury A; Rohde K; Bejanin S; Essioux L; Schuster H; Luft FC; Reich JG
    Hum Mol Genet; 2002 Jun; 11(12):1477-85. PubMed ID: 12023990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin:cholesterol acyltransferase in high-density lipoprotein cholesterol elevation.
    Nishiwaki M; Ishikawa T; Ito T; Shige H; Tomiyasu K; Nakajima K; Kondo K; Hashimoto H; Saitoh K; Manabe M
    Atherosclerosis; 1994 Nov; 111(1):99-109. PubMed ID: 7840818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia.
    Durrington PN; Mackness MI; Bhatnagar D; Julier K; Prais H; Arrol S; Morgan J; Wood GN
    Atherosclerosis; 1998 May; 138(1):217-25. PubMed ID: 9678787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
    Subramanian VS; Goyal J; Miwa M; Sugatami J; Akiyama M; Liu M; Subbaiah PV
    Biochim Biophys Acta; 1999 Jul; 1439(1):95-109. PubMed ID: 10395969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High density lipoprotein metabolism in the horse (Equus caballus).
    Watson TD; Burns L; Freeman DJ; Packard CJ; Shepherd J
    Comp Biochem Physiol B; 1993 Jan; 104(1):45-53. PubMed ID: 8448992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse models.
    Ma K; Forte T; Otvos JD; Chan L
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):149-54. PubMed ID: 15539616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid transfer proteins, hypertriglyceridemia, and reduced high-density lipoprotein cholesterol.
    Sparks D; Frohlich JJ; Pritchard PH
    Am Heart J; 1991 Aug; 122(2):601-7. PubMed ID: 1858655
    [No Abstract]   [Full Text] [Related]  

  • 39. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
    Moradi H; Pahl MV; Elahimehr R; Vaziri ND
    Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent advanced knowledges related with lipoprotein metabolism].
    Shimada K; Mokuno H
    Nihon Rinsho; 1999 Dec; 57(12):2717-22. PubMed ID: 10638202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.